Anand Reddi is a graduate of the University of Michigan, Ann Arbor with degrees in biology and history. In 2005, Reddi was a Fulbright Scholar assisting the Sinikithemba HIV/AIDS clinic at McCord Hospital in Durban, South Africa. Currently, he is completing his medical training at the University of Colorado School of Medicine.
Reddi's basic science research focuses on the molecular mechanisms involved in skin cancer tumor initiation and metastasis. He is also interested in U.S. global health policy with a special focus on the provision of HIV/AIDS antiretroviral therapy in resource-limited settings. His Fulbright research in South Africa, in collaboration with Sarah Leeper, demonstrated that pediatric antiretroviral therapy is effective despite the challenges of a resource-limited setting.
Reddi is a frequent contributor to The Huffington Post as a featured blogger. In the summer of 2010, Reddi’s advocacy challenged the Obama Administration’s flat lining of global HIV treatment funds for The President's Emergency Plan for AIDS Relief (PEPFAR). His other public health interests include: disclosure of academic-industry financial ties during medical education, initiatives to strengthen African healthcare systems such as the use of human capital contracts for global health.
Anand Reddi is the recipient of the University of Colorado's Thomas Jefferson Award. The Jefferson prize, one of the highest honors bestowed by the University of Colorado, recognized Reddi's efforts in protecting the provision of AIDS medications in resource-limited settings around the world. His other notable honors include an: American Medical Association Foundation Leadership Award, Edwin E. Osgood Research Award from the American Federation for Medical Research and attainment of the Eagle Scout Rank from the Boy Scouts of America. From 2009 to 2011, Reddi served on the board of directors of the AIDS Healthcare Foundation.